BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15788667)

  • 1. Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases.
    Li J; Guo K; Koh VW; Tang JP; Gan BQ; Shi H; Li HX; Zeng Q
    Clin Cancer Res; 2005 Mar; 11(6):2195-204. PubMed ID: 15788667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRL-3 expression in metastatic cancers.
    Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
    Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer.
    Peng L; Ning J; Meng L; Shou C
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):521-6. PubMed ID: 15133662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phosphatase associated with metastasis of colorectal cancer.
    Saha S; Bardelli A; Buckhaults P; Velculescu VE; Rago C; St Croix B; Romans KE; Choti MA; Lengauer C; Kinzler KW; Vogelstein B
    Science; 2001 Nov; 294(5545):1343-6. PubMed ID: 11598267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRL-3 phosphatase is implicated in ovarian cancer growth.
    Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
    Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
    Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
    Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of monoclonal antibody against protein tyrosine phosphatase PRL-3.
    Peng L; Li Y; Meng L; Shou C
    Hybrid Hybridomics; 2004 Feb; 23(1):23-7. PubMed ID: 15000845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
    Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
    J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
    Molinolo A; Simpson JF; Thor A; Schlom J
    Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.
    Ikeda S; Fujimori M; Shibata S; Okajima M; Ishizaki Y; Kurihara T; Miyata Y; Iseki M; Shimizu Y; Tokumoto N; Ozaki S; Asahara T
    BMC Cancer; 2006 Feb; 6():31. PubMed ID: 16451736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tetranectin: methodological and clinical studies.
    Høgdall CK
    APMIS Suppl; 1998; 86():1-31. PubMed ID: 9868384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1.
    Zeng Q; Hong W; Tan YH
    Biochem Biophys Res Commun; 1998 Mar; 244(2):421-7. PubMed ID: 9514946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and distribution of thioredoxin-like 2 as the antigen for the monoclonal antibody MC3 specific to colorectal cancer.
    Lu Y; Wang X; Liu Z; Jin B; Chu D; Zhai H; Zhang F; Li K; Ren G; Miranda-Vizuete A; Guo X; Fan D
    Proteomics; 2008 Jun; 8(11):2220-9. PubMed ID: 18528843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.